{"url_path":"/sec/guts/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1572616/0001193125-26-303948-index.html","accession_number":"0001193125-26-303948","cik":"0001572616","ticker":"GUTS","issuer_name":"FRACTYL HEALTH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1572616/0001193125-26-303948-index.html","primary_entity_key":"0001572616","primary_entity_name":"FRACTYL HEALTH, INC."},"word_count":91,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\nExhibit No\n\nDescription\n\n99.1\n\n[Press Release dated July 15, 2026](guts-ex99_1.htm)\n\n99.2\n\n[Conference Call Presentation dated July 15, 2026](guts-ex99_2.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n##  \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nFractyl Health, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nJuly 15, 2026\n\nBy:\n\n/s/ Harith Rajagopalan\n\n \n\n \n\n \n\nHarith Rajagopalan, M.D., Ph.D.,\nCo-Founder, Chief Executive Officer and Director\n(Principal Executive Officer)"}